{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:00:27Z","timestamp":1783119627199,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670150"],"award-info":[{"award-number":["81670150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clml.2020.10.009","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T21:50:50Z","timestamp":1603489850000},"page":"e198-e205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study"],"prefix":"10.1016","volume":"21","author":[{"given":"Baihua","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.10.009_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.clml.2020.10.009_bib2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Rosee","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2020.10.009_bib4","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00277-016-2805-9","article-title":"Clinical features and survival of extranodal natural killer\/T cell lymphoma with and without hemophagocytic syndrome","volume":"95","author":"Jia","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.10.009_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/bjh.12823","article-title":"Risk factor analysis of non-Hodgkin lymphoma\u2013associated haemophagocytic syndromes: a multicentre study","volume":"165","author":"Sano","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.10.009_bib6","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib7","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.10.009_bib8","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib9","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.10.009_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clml.2020.10.009_bib12","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A\u00a0clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib13","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1002\/cam4.1669","article-title":"Primary bone marrow lymphoma: a hematological emergency in adults with fever of unknown origin","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.clml.2020.10.009_bib14","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00432-015-2094-z","article-title":"The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable","volume":"142","author":"Wang","year":"2016","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clml.2020.10.009_bib15","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/annonc\/mdu109","article-title":"Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era","volume":"25","author":"Vaidya","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2020.10.009_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.10.009_bib17","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00277-013-1784-3","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution","volume":"92","author":"Yu","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.10.009_bib19","first-page":"1275","article-title":"Lymphoma associated hemophagocytic syndrome: a single-center retrospective study","volume":"16","author":"Chang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clml.2020.10.009_bib20","article-title":"Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin\u2019s lymphoma\u2013associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase 2 trial","author":"Liang","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.10.009_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12185-019-02623-z","article-title":"Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series","volume":"109","author":"Pasvolsky","year":"2019","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2020.10.009_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2003-12-4197","article-title":"Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients","volume":"104","author":"Au","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.hoc.2015.06.009","article-title":"Hemophagocytic lymphohistiocytosis in adults","volume":"29","author":"Campo","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.clml.2020.10.009_bib24","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","article-title":"A\u00a0distinct subtype of Epstein-Barr virus\u2013positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection\u2013like features","volume":"103","author":"Kawamoto","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.10.009_bib25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.10.009_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","article-title":"Epstein-Barr virus\u2013associated lymphomas","volume":"42","author":"Grywalska","year":"2015","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2020.10.009_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jmv.1890280211","article-title":"Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection","volume":"28","author":"Joncas","year":"1989","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.clml.2020.10.009_bib28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","article-title":"Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation","volume":"103","author":"Katano","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jmv.1029","article-title":"Impaired cytotoxic T lymphocyte response to Epstein-Barr virus\u2013infected NK cells in patients with severe chronic active EBV infection","volume":"64","author":"Tsuge","year":"2001","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.clml.2020.10.009_bib30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1086\/423285","article-title":"Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection","volume":"190","author":"Sugaya","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.clml.2020.10.009_bib31","doi-asserted-by":"crossref","first-page":"ofz171","DOI":"10.1093\/ofid\/ofz171","article-title":"Determination of Epstein-Barr virus\u2013infected lymphocyte cell types in peripheral blood mononuclear cells as a valuable diagnostic tool in hematological diseases","volume":"6","author":"Zhang","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.clml.2020.10.009_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjh.13102","article-title":"Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide","volume":"168","author":"Arca","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.10.009_bib33","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00134-010-1936-z","article-title":"Critical care management of patients with hemophagocytic lymphohistiocytosis","volume":"36","author":"Buyse","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clml.2020.10.009_bib34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.clml.2020.10.009_bib35","doi-asserted-by":"crossref","first-page":"e1692","DOI":"10.1097\/MD.0000000000001692","article-title":"Coagulation disorders and bleedings in critically ill patients with hemophagocytic lymphohistiocytosis","volume":"94","author":"Valade","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clml.2020.10.009_bib36","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00134-008-1111-y","article-title":"Understanding organ dysfunction in hemophagocytic lymphohistiocytosis","volume":"34","author":"Creput","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.clml.2020.10.009_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/PAP.0b013e3182862724","article-title":"Next-generation sequencing discoveries in lymphoma","volume":"20","author":"Slack","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.clml.2020.10.009_bib38","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood-2016-03-635219","article-title":"Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma","volume":"127","author":"Roschewski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.10.009_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.clml.2020.10.009_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3346\/jkms.2008.23.3.439","article-title":"Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis","volume":"23","author":"Shin","year":"2008","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.clml.2020.10.009_bib41","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","article-title":"Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:36:21Z","timestamp":1761870981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020305760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2152265020305760"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.10.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}